PEOPLE - Changes at Diagnostic Products(US):
This article was originally published in Clinica
Julian Bockserman is to retire as vice-president of finance and chief financial officer of US company Diagnostic Products later this year. He will be succeeded by James Brill who was most recently CFO of Jafra Cosmetics.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.